What is the current IGC Pharma market capitalization?
The current market capitalization of IGC Pharma is 20.84 M USD.
IGC Pharma Market capitalization 2024
IGC Pharma Market capitalization
20.84 M USD
Ticker
IGC
ISIN
US45408X3089
WKN
A1T87A
In 2024, IGC Pharma's market cap stood at 20.84 M USD, a 18.38% increase from the 17.6 M USD market cap in the previous year.
The IGC Pharma Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2024 | 20.84 |
| 2023 | 17.94 |
| 2022 | 31.68 |
| 2021 | 68.97 |
| 2020 | 34.16 |
| 2019 | 40.87 |
| 2018 | 33.71 |
| 2017 | 10.83 |
| 2016 | 6.46 |
| 2015 | 5.32 |
| 2014 | 7.59 |
| 2013 | 10.64 |
| 2012 | 7.32 |
| 2011 | 6.21 |
| 2010 | 12.09 |
| 2009 | 11.37 |
| 2008 | 36.92 |
| 2007 | 80.29 |
| 2006 | 77.17 |
IGC Pharma Aktienanalyse
What does IGC Pharma do?
India Globalization Capital Inc. (IGC) is a Maryland-based company that focuses on the development, marketing, and sale of natural supplements, novel cannabis formulations, food and beverages, and the manufacturing of medical devices. IGC was established in 2005 and initially operated as a construction company in India. However, over the years, the company has evolved into a diversified company based in Maryland due to its innovative products and services. One of IGC's most well-known divisions is IGC Pharma, which focuses on cannabis-based medical formulations and medical devices. IGC holds patent applications for certain cannabis-based products and was one of the first companies to explore the use of cannabis as a potential treatment for Alzheimer's patients. In collaboration with the Institute for Medicine and the Origins of Infancy at the University of Maryland, IGC developed a novel THC-based medication for the treatment of spasms, pain, and other symptoms in multiple sclerosis patients. IGC has also developed the "Hyalolex" product, which is made from specific cannabinoids such as CBD. This preparation is available in Germany under the trade name "Cannabidiol Hexal." Hyalolex is available as a dietary supplement and has been proven effective in improving memory performance, attention, and cognitive abilities in Alzheimer's patients. IGC also operates the IGC Nutraceuticals division, which focuses on the manufacturing and marketing of high-quality natural products. These include vitamins, minerals, dietary supplements, and natural herbal supplements that promote physical and mental well-being and support healthy bodily processes. Some of IGC Nutraceuticals' products include Saffron for Depression Relief, the calcium and magnesium formulation, and Bharat Diagnostics. IGC will continue to invest in various fields, including cannabis-based pain relief, dementia treatments, electrochemical energy storage, and the manufacturing of devices that utilize natural resources such as coal and ore. Overall, IGC has become a diversified company that focuses on a variety of industries. IGC has been a pioneer in the cannabis industry and has gained a good reputation through innovative formulations and patents. By expanding into new industries and investing in new technologies, IGC will continue to stay at the forefront of innovation and strengthen its position as one of the emerging development companies in today's economy. IGC Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring IGC Pharma's Market Capitalization
IGC Pharma's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of IGC Pharma's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
IGC Pharma's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in IGC Pharma’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about IGC Pharma stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like IGC Pharma.
How has the market capitalization of IGC Pharma developed in recent years?
The market capitalization of IGC Pharma has increased/decreased by 18.38% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of IGC Pharma?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of IGC Pharma?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of IGC Pharma have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does IGC Pharma pay?
Over the past 12 months, IGC Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IGC Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of IGC Pharma?
The current dividend yield of IGC Pharma is .
When does IGC Pharma pay dividends?
IGC Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of IGC Pharma?
IGC Pharma paid dividends every year for the past 0 years.
What is the dividend of IGC Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is IGC Pharma located?
IGC Pharma is assigned to the 'Industry' sector.
Wann musste ich die Aktien von IGC Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of IGC Pharma from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.
When did IGC Pharma pay the last dividend?
The last dividend was paid out on 9/30/2024.
What was the dividend of IGC Pharma in the year 2023?
In the year 2023, IGC Pharma distributed 0 USD as dividends.
In which currency does IGC Pharma pay out the dividend?
The dividends of IGC Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The IGC Pharma stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von IGC Pharma
Our stock analysis for IGC Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IGC Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
